Clinical trial
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or…
NCT00101309 · Milton S. Hershey Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00101309 |
|---|---|
| Title | Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma |
| Official title | A Phase I Pilot Study of Tumor Cell - B Lymphoblastoid Cell Line Vaccination in Pediatric Subjects With Relapsed Ewing's Sarcoma and Neuroblastoma |
| Lead sponsor | Milton S. Hershey Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma, Sarcoma |
| Intervention type | Biological |
| Interventions | aldesleukin, autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine, therapeutic autologous lymphocytes |
| Enrollment | 10 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2007 |
| First posted | Jan 10, 2005 |
| Last update posted | Dec 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: